A Prospective Randomized Open Label Blinded Endpoint Multicenter Study in Patients With Coronary Artery Disease to Assess the LDL Lowering Effect of Switching to Ezetimibe (+) Simvastatin for Cholesterol Lowering, Compared the Dose of the Statin Used.
Latest Information Update: 19 Aug 2024
Price :
$35 *
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin; Simvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms EASEGO
- Sponsors Organon
- 24 Oct 2009 Results of an economic analysis were presented at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
- 29 Oct 2005 New trial record.